Stock listing

Frankfurt:9EN Pharvaris N.V. Aktie

German listing (Frankfurt) of Pharvaris N.V. · home listing NASDAQ:PHVS

Follow Pharvaris N.V. into a list and get an email when it puts out news.

Share price · FWB:9EN

€28.30 EUR +0.55 (+2.0%)

Close on Oct 27, 2026

Day range
€27.80 – €28.95 EUROct 27, 2026
Market cap
€1.99B EURAt the close on Oct 27, 2026 · price × 70.20M shares outstanding
Pharvaris N.V. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:PHVS · Home$33.53 USD-0.05 (-0.1%)1,481,526$33.48$33.94$33.05$33.58Close on Oct 30, 2026
Frankfurt:9EN€28.30 EUR+0.55 (+2.0%)—€27.80€28.95€27.80€27.75Close on Oct 27, 2026
Ticker
Frankfurt:9EN
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

What changed lately

Latest news

Pharvaris to Present Clinical and Real-World Data at the ACAAI 2026 Annual Scientific Meeting

Oct 29, 2026

Real-World Analysis Highlighting HAE Disease Experience and Gaps in Treatment Satisfaction Published in Advances in Therapy

Oct 5, 2026

Pharvaris Announces Positive Topline Data from CHAPTER-3 Pivotal Study of Deucrictibant XR for Prophylaxis of HAE Attacks

Sep 8, 2026

Pharvaris Presents Translational, Nonclinical, and Clinical Data at Bradykinin Symposium 2026

Sep 3, 2026

Pharvaris Reports Second Quarter 2026 Financial Results and Provides Business Update

Aug 12, 2026

Publication in Clinical Reviews in Allergy & Immunology Summarizes Decades of Evidence Supporting Bradykinin B2 Receptor as a Validated Therapeutic Target in Bradykinin-Mediated Angioedema

Jul 22, 2026

Pharvaris Announces FDA Acceptance of New Drug Application for Deucrictibant IR for On-Demand Treatment of Hereditary Angioedema Attacks

Jul 6, 2026

Data Supporting Differentiated Profile of Deucrictibant in HAE Management Presented at EAACI 2026

Jun 15, 2026

Pharvaris Announces Annual General Meeting of Shareholders

Jun 11, 2026

Pharvaris to Present Clinical Data at the EAACI Annual Congress 2026

May 29, 2026

All Pharvaris N.V. news

Decks

Pharvaris N.V. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
22 in the last 12 months · 128 in all · newest Oct 29, 2026 · oldest 2021
Decks
19 decks · latest October 2026

Where Pharvaris N.V. is listed

ListingExchangeCountryCurrency
NASDAQ:PHVS · Home listingNASDAQUnited StatesUSD
gettex:9ENgettexGermanyEUR
LS Exchange:A2QNWSLS ExchangeGermanyEUR
Tradegate:9ENTradegateGermanyEUR
BOATS:PHVSBOATSUnited StatesUSD
Lang & Schwarz:A2QNWSLang & SchwarzGermanyEUR
Frankfurt:9EN · This pageFrankfurtGermanyEUR
Dusseldorf:9ENDusseldorfGermanyEUR
Munich:9ENMunichGermanyEUR
Stuttgart:9ENStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Pharvaris N.V.